Mutation of RANKL, and pharmaceutical composition for preventing or treating osteoporosis comprising the same

摘要

The present invention can inhibit the production of osteoclasts by inducing the production of anti-RANKL antibodies as antigens in the body, and binds to RANK, but does not induce differentiation of osteoclasts and contains mutants of RANKL protein and active ingredients thereof , It relates to the provision of a composition for preventing or treating bone metabolic disease.